0001193125-15-336621 Sample Contracts

MYRIAD GENETICS, INC. Amendment to Executive Retention Agreement

Executive Retention Agreement • October 2nd, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Executive Retention Agreement
• Filed
  October 2nd, 2015
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS AMENDMENT TO EXECUTIVE RETENTION AGREEMENT (the “Amendment”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is entered into effective as of September 29, 2015 (the “Effective Date”).